Functional hyperemia is the regional increase in cerebral blood flow upon increases in neuronal activity which ensures that the metabolic demands of the neurons are met. Hypertension is known to impair the hyperemic response; however, the neurovascular coupling mechanisms by which this cerebrovascular dysfunction occurs have yet to be fully elucidated. To determine whether altered cortical parenchymal arteriole function or astrocyte signaling contribute to blunted neurovascular coupling in hypertension, we measured parenchymal arteriole reactivity and vascular smooth muscle cell Ca 2+ dynamics in cortical brain slices from normotensive Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats. We found that vasoconstriction in response to the thromboxane A 2 receptor agonist U46619 and basal vascular smooth muscle cell Ca 2+ oscillation frequency were significantly increased in parenchymal arterioles from SHR. In perfused and pressurized parenchymal arterioles, myogenic tone was significantly increased in SHR. Although K + -induced parenchymal arteriole dilations were similar in WKY and SHR, metabotropic glutamate receptor activation-induced parenchymal arteriole dilations were enhanced in SHR. Further, neuronal stimulation-evoked parenchymal arteriole dilations were similar in SHR and WKY. Our data indicate that neurovascular coupling is not impaired in SHR, at least at the level of the parenchymal arterioles. Keywords: astrocytes; brain slice; cerebral blood flow; hypertension; neurovascular coupling; parenchymal arterioles INTRODUCTION Functional hyperemia (FH), the process in which neuronal activation triggers local increases in cerebral blood flow (CBF), is of particular importance for cerebral homeostasis as it ensures that neuronal metabolic demands are met. 1 Despite recent controversy, 2,3 numerous in vitro and in vivo studies suggest that astrocytes act as intermediaries in the neurovascular coupling (NVC)-mediated vascular responses that govern the hyperemic response. Although NVC-mediated signaling can elicit both vasodilation and vasoconstriction, the focus of this study is to address NVC-mediated vasodilatory responses. During the orchestrated signaling among neurons, astrocytes, and the cerebral vasculature that occurs during NVC-mediated vasodilation, synaptically released glutamate binds to astrocytic metabotropic glutamate receptors (mGluR) increasing intracellular Ca 2+ , 1,4 which, in turn, results in the release of vasoactive signals such as arachidonic acid (AA) metabolites 4 and K + . 5 Although FH is impaired in hypertensive patients and animal models of hypertension, 6-9 the mechanisms by which hypertension disrupts NVC among cells in the neurovascular unit is not fully understood. A few elegantly designed studies, primarily evaluating pial arteriole function, have used regional CBF measurements to deliver valuable insight into the vascular mechanisms underlying NVC disruptions during acute, short-term Angiotensin II-induced hypertension 6,9 and chronic hypertension. 8 However,